Treace Medical Concepts, Inc. (TMCI)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Treace Medical Concepts Inc (TMCI) Q2 2024 Earnings Call Transcript
Treace Medical Concepts Inc (TMCI) Q2 2024 Earnings Call Transcript
Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates
Treace Medical Concepts (TMCI) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.20 per share a year ago.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
NEW YORK, NY / ACCESSWIRE / June 9, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
NEW YORK CITY, NY / ACCESSWIRE / June 1, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or the "Company") (NASDAQ:TMCI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
